• No results found

Pulmonary embolism : diagnostic management and prognosis Klok, F.A.

N/A
N/A
Protected

Academic year: 2021

Share "Pulmonary embolism : diagnostic management and prognosis Klok, F.A."

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Pulmonary embolism : diagnostic management and prognosis

Klok, F.A.

Citation

Klok, F. A. (2010, March 2). Pulmonary embolism : diagnostic management and prognosis. Retrieved from

https://hdl.handle.net/1887/15031

Version: Corrected Publisher’s Version License:

Licence agreement concerning inclusion

of doctoral thesis in the Institutional

Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/15031

Note: To cite this publication please use the final published

version (if applicable).

(2)

Stellingen behorende bij het proefschrift

“Pulmonary Embolism: Diagnostic management and prognosis”

1. Further simplification of the ‘revised Geneva score’ does not lead to a decrease in diagnostic accuracy or clinical utility of this diagnostic prediction rule. –this thesis 2. Wide scale implementation of prolonged follow-up including echocardiography of all

patients with pulmonary embolism to detect CTEPH seems not warranted. - this thesis 3. Ruling out CTEPH in patients after acute pulmonary embolism is safe without additional

diagnostic testing in absence of ECG criteria indicative of right ventricular hypertrophy and a normal NT-pro-BNP level. - this thesis

4. The care for a patient suffering from acute pulmonary embolism includes more then monitoring anticoagulant therapy. - this thesis

5. Longembolie is een ziekte die zowel patiënt als dokter aan het hart gaat.

-dit proefschrift

6. Because of the sharp increase in admissions for myocardial infarctions during and after penalty kicks following an undecided soccer match, it could be considered on medical grounds to abandon publically performed penalty series. -Carrol D et al, BMJ 2002:

325:1439–42

7. Diagnostic models are often not applied in daily practice since clinicians are reluctant to accept that such tools are not meant to be a substitute for clinical experience and skills, but to strengthen them. This latter opinion is clearly a misunderstanding.

- Grobbee et al, Clinical epidemiology, Jones and Bartlett Publishers 2009

8. The challenge for the physician in any diagnostic process not only lies in choosing the optimal diagnostic tests and in what to order, but also in knowing when to stop testing.

-Grobbee et al, Clinical epidemiology, Jones and Bartlett Publishers 2009

9. In principal, causality is a researchers’ interpretation. –Hill AB, Proc R Soc Med 1965;

58:295-300

10. The curse of king Toetanchamon that predicted a swift death to all who disturbed his tomb, has failed. –Nelson MR, BMJ 2002; 325:1482-4.

11. Do, or do not. There is no try. -Yoda, Star Wars Episode V

12. When you do not encounter a headwind, you are cycling too slowly. –Road racing cyclists’ philosophy

Referenties

GERELATEERDE DOCUMENTEN

In summary, elevated levels of BNP or NT-pro-BNP are indicators of right ventricular dysfunction in patients with acute PE and strong risk factors for short term mortality as well

In summary, right ventricular enlargement and elevated cardiac biomarkers, that are indepen- dently associated with acute PE, are predictive for a complicated clinical course

In conclusion, RV ejection fraction, obtained with ECG-synchronized cardiac CT was found the best predictor for clinical outcome in patients with acute PE, although only of

In addition, information on known risk factors for venous thromboembolism (VTE) and CTEPH were noted down. The latter includes large central emboli, unprovoked VTE,

Although all biochemical tests under study have been shown to be correlated to the presence and/or prognosis of pulmonary hypertension 8-13 , and almost all tests were more

19 patients previously diagnosed with pulmonary hypertension and 402 who completed the cardiopulmonary work-up, are depicted in Table 1: mean age was 55 years, 225 (53%) were

Cumulative arterial cardiovascular event rate in patients with unprovoked pulmonary embolism (PE), with provoked PE and in control patients without PE starting after a six

Many risk stratification and screening strategies including intensified or prolonged anti- thrombotic therapy regimes to identify and treat patients with high risk for PE-related